Wira Winardi, Hendra Wahyuni, Moulid Hidayat, Aditya Wirawan, Fariz Nurwidya, Mohammad N. Uddin, Mohamad Yusup
Indonesia is among the top three countries globally with the highest tuberculosis burden. During the past decades, Indonesian health authorities have struggled to improve tuberculosis care quality in health care facilities by optimizing the regulation and strengthening the private sector contributions. The coronavirus disease 2019 (COVID-19) pandemic has hardly affected the Indonesian health care system, including the National Tuberculosis Control Program. While the end of the COVID-19 pandemic in Indonesia is uncertain, the measure to control tuberculosis must not be weakened. Early identification and measurement of the problem size are essential to decide the most appropriate approach to maintain the sustainability of National Tuberculosis Control Program, particularly in health care facilities during the COVID-19 pandemic. This article points out the possible threats to the sustainability of TB care in Indonesia during the COVID-19 pandemic, including some approaches to overcome those problems. © 2022, School of Medicine, Universitas Syiah Kuala. All rights reserved.
Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Indonesia; Faculty of Medicine, Universitas Mataram, Indonesia; Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Indonesia, Jakarta, Indonesia; Genomic and Regenerative Medicine Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Japan; Kawakita General Hospital, Tokyo, Japan
Research at a Glance
Register to unlockTopics & SDG Alignment
Register to unlockCollaboration
Register to unlockAuthor Profile (Selected)
Register to unlockReferences Overview
Register to unlockJournal & Source
Register to unlockMetadata & Integrity
Register to unlock